Background To explore the correlation between the preoperative systemic immune
inflammation index (SII) and the prognosis of patients with gastric carcinoma (GC). Methods …

Background Since inflammation and the immune system contribute to the development and
progression of malignancies, parameters that reflect a host's immune-inflammatory status …

Background Systemic immune–inflammation index (SII), calculated by immunoinflammatory
cell counts of peripheral blood, is considered a predictor of survival outcome in several solid …

Background The inflammatory reaction, which plays a key role in tumor microenvironment, is
associated with the tumor development, progression and metastasis. We aim to estimate the …

OBJECTIVE: The aim of this study is to explore the potential value of high preoperative
systemic immune-inflammation index (SII) expression in the prognosis of patients with …

Background/Aim: The systemic inflammation score (SIS) is a promising tool for the
evaluation of prognosis. The present study aimed to evaluate the clinical impact of the …

Background and objective A novel systemic immune–inflammation index named SII (SII= N×
P/L), which is based on neutrophil (N), platelet (P) and lymphocyte (L) counts, has emerged …

Background: Systemic immune-inflammation index (SII)—comprising platelet, neutrophil,
and lymphocyte count—is an objective and reliable biomarker for predicting the prognosis in …

Objective To investigate the impact of preoperative systemic immune inflammatory index
(SII) on the clinical prognosis of patients undergoing colorectal cancer (CRC) surgery …

Background The systemic immune-inflammation index (SII), integrated by peripheral
lymphocyte, neutrophil, and platelet counts, is used as an objective biomarker that reflects …